14. June 2022
Read the Latest News or Download our Publications.
7. June 2022
From CPUs to BPUs - a new generation of biocompatible semiconductors for rapid amplification-free genotyping being introduced at AGBT
San Diego, CA and Orlando, FL -- June 7, 2022 -- Today, at the prestigious Advances in Genome...
7. June 2022
AGBT 2022 abstract by Dr. Kiana Aran: From CPUs to BPUs : a new generation of transistors for rapid amplification-free genotyping
Introducing the first-generation DNA targeted BPUs that combine CRISPR technology with the...
3. May 2022
Cardea Bio receives funding to develop electronic nose to rapidly diagnose infectious diseases via breath
Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors -...
27. April 2022
Securing international patents for mass-produced graphene biosensors
Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their...
5. April 2022
Cardea Bio completes planned launch of CRISPR QC
San Diego, CA -- April 5, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
8. March 2022
Nature Awards Webcasts: Kiana Aran and the future of CRISPR technology
An exciting and inspiring session with our Chief Scientific Officer, Kiana Aran, on the future of...
2. February 2022
Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies
Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran...
10. January 2022
Cardea announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications
San Diego, CA -- January 10, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
9. December 2021